HCM
RMD icon

Highbridge Capital Management’s ResMed RMD Stock Holding History

Highbridge Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,300
Closed -$228K – 1269
2018
Q1 		$228K Buy
+2,300
New +$217K ﹤0.01% 1001
2015
Q3 		– Sell
-8,400
Closed -$473K – 1779
2015
Q2 		$473K Sell
8,400
-4,100
-33% -$259K 0.01% 995
2015
Q1 		$898K Buy
+12,500
New +$812K 0.01% 787

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Highbridge Capital Management's RMD Position: Q2 2019 in Review

Highbridge Capital Management sold out of ResMed (RMD) in Q2 2019, closing a stake of 22,400 shares — an estimated $2.33M sold.

Highbridge Capital Management first reported a position in RMD in Q3 2013 and held it in 11 quarters. The position peaked at $11M in Q3 2015. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2019.

  • Highbridge Capital Management reported no remaining ResMed position as of Q2 2019 after selling out during the quarter.
  • Highbridge Capital Management sold 22,400 ResMed shares in Q2 2019, an estimated $2.33M.
  • Highbridge Capital Management first reported a position in ResMed in Q3 2013 and held it in 11 quarters.
  • Highbridge Capital Management's ResMed position peaked at $11M in Q3 2015.
  • 485 funds tracked by Wall St. Rank held ResMed as of Q2 2019.

Based on Highbridge Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.